HRB National Drugs Library e-newsletter volume 18, issue 12

In this issue

International publications

Homelessness and drugs: health and social responses.

(2022) Lisbon: EMCDDA

Families of people who use drugs: health and social responses.

(2022) Lisbon: EMCDDA

Lisbon declaration (to be adopted at the 18th Ministerial Conference of the Council of Europe Pompidou Group). Pompidou Group

(2022) Strasbourg: Council of Europe.

Presentation recording: Getting it right for women with a drug problem: issues and improving practice.

MacLeod, Katy (2022) In: SDF conference - Getting It right: realistic approaches to complex needs., 5 October 2022, Glasgow.

The stigma-vulnerability nexus and the framing of drug problems.

Alexandrescu, Liviu and Spicer, Jack (2022) Drugs: Education Prevention and Policy, doi.org/10.1080/09687637.2022.2049214

Complexities and conveniences in the international drug trade: the involvement of Mexican criminal actors in the EU drug market.

Europol, Drug Enforcement Administration. (2022) Europol.

Trends in intentional abuse and misuse ingestions in school-aged children and adolescents reported to US poison centers from 2000-2020.

Hughes, Adrienne R et al (2022) Clinical Toxicology, pp. 1-8. doi.org/10.1080/15563650.2022.2120818

School-based peer education interventions to improve health: a global systematic review of effectiveness.

Dodd, Steven et al (2022) BMC Public Health, 22. doi: 10.1186/s12889-022-14688-3

Exploring arts-based interventions for youth substance use prevention: a scoping review of literature.

Maina, Geoffrey et al (2022) BMC public health, 22. doi: 10.1186/s12889-022-14714-4

A guide to common drug names in Scotland.

RADAR. (2022) Edinburgh: Public Health Scotland

Substance use, Alcohol and Behavioural Addictions in Autism (SABAA) project.

Calder, Robert et al (2022) London: Society for the Study of Addiction.

Co-occurring substance use and mental health concerns in Scotland: a review of the literature and evidence.

(2022) Edinburgh: Scottish Government.

Webinar: Treatment, recovery and integrated care systems – what does it all mean?

(2022) Collective Voice.

Providing substance use disorder treatment in correctional settings: knowledge gaps and proposed research priorities-overview and commentary.

Zaller, Nickolas D et al (2022) Addiction Science & Clinical Practice, 17. doi: 10.1186/s13722-022-00351-0

Palliative care for people who use drugs during communicable disease epidemics and pandemics: a scoping review on access, policies, and programs and guidelines.

Buchman, Daniel Z et al (2022) Palliative Medicine, doi: 10.1177/02692163221143153.

Connecting the dots: tackling mental health inequalities in Wales.

Welsh Parliament, Health and Social Care Committee. (2022) Cardiff: Senedd Commission.

Report on the progress made in the fight against trafficking in human beings (fourth report).

(2022) Brussels: European Commission.

Recreational drug misuse and its potential contribution to male fertility levels' decline: a narrative review.

Schifano, Nicolò et al (2022) Brain Sciences, 12, (11). doi.org/10.3390/brainsci12111582

EMCDDA webinar: How wastewater monitoring can boost preparedness for new health threats.

(2022) EMCDDA

Monitoring drug use in the digital age: studies in web surveys. European web survey on drugs: an overview of the project.

EMCDDA. Matias, Joao (2022) Luxembourg: Publications Office of the European Union.

Quantitative and qualitative assessments of data quality within the European Web Survey on Drugs.

Kalamara, Eleni and Skarupova, Katerina, eds. (2022) Luxembourg: Publications Office of the European Union.

Substance residue analysis as an alternative to drug checking? Traces from drug paraphernalia as a source for laboratory analysis.

Kaskela, Teemu et al (2022) Drugs, Habits and Social Policy, 23, (3), pp. 277-288. doi.org/10.1108/DHS-12-2021-0063

A distributed model to expand the reach of drug checking.

Wallace, Bruce et al (2022) Drugs, Habits and Social Policy, 23, (3), pp. 220-231. doi.org/10.1108/DHS-01-2022-0005

Drug Abuse Warning Network (DAWN): findings from drug-related emergency department visits, 2021.

(2022) Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration

Adolescent substance use and risk behaviours in the Mediterranean region. Fourth MEDSPAD regional report.

MedSPAD Group. Benedetti, Elisa et al (2022) Brussels: Council of Europe.

The Illicit Drug Reporting System (IDRS).

National Drug and Alcohol Research Centre (2022)

The Ecstasy and Related Drugs Reporting System (EDRS).

National Drug and Alcohol Research Centre (2022)

Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances.

Di Trana, Annagiulia et al (2022) International Journal of Molecular Sciences, 23, (23), 14619. doi: 10.3390/ijms232314619.

Synthetic opioids: a review and clinical update.

Shafi, Abu and Berry, et al (2022) Therapeutic Advances in Psychopharmacology, 12. doi.org/10.1177/20451253221139616

EMCDDA framework and practical guidance for naming synthetic cannabinoids.

Pulver, Benedikt et al (2022) Drug Testing and Analysis, Early online. doi: 10.1002/dta.3403

From JWH-018 to OXIZIDS: structural evolution of synthetic cannabinoids in the European Union from 2008 to present day.

Andrews, Rachael et al (2022) Drug Testing and Analysis, Early online. doi: 10.1002/dta.3422 (In Press)

ACMD advice on the classification and schedule of Remimazolam.

(2022) London: Advisory Council on the Misuse of Drugs.

The increase in benzodiazepine-laced drugs and related risks in Canada: the urgent need for effective and sustainable solutions.

Russell, Cayley et al (2022) International Journal of Drug Policy, 111. doi: 10.1016/j.drugpo.2022.103933

The benzo research project: an evaluation of recreational benzodiazepine use amongst UK young people (18-25).

Ezquerra-Romano, Ivan et al (2022) London: Benzo Research Project

Global SMART update volume 27: “Tuci”, “happy water”, “k-powdered milk” – is the illicit market for ketamine expanding?

(2022) Vienna: United Nations Office on Drugs and Crime.

Mechanisms involved in the neurotoxicity and abuse liability of nitrous oxide: a narrative review

Brunt, Tibor M et al (2022) International Journal of Molecular Sciences, 23, (23). doi: 10.3390/ijms232314747

Editorial: Supervised drug consumption sites: a health-based approach or enabling drug use?

Abram, Marissa D et al (2022) Journal of Clinical Nursing, Early online. doi: 10.1111/jocn.16596

Patterns of mortality risk among patients with substance use disorder: an opportunity for proactive patient safety?

Svensson, Jakob et al (2022) BMC Psychiatry, 22, 770. doi.org/10.1186/s12888-022-04437-6

Deaths in prison. Examining causes, responses, and prevention of deaths in prison worldwide.

London: Prison Reform International. Penal Reform International, University of Nottingham. (2022)

Risk of COVID-19 infection and the associated hospitalization, ICU admission and mortality in opioid use disorder: a systematic review and meta-analysis.

Behnoush, Amir Hossein et al (2022) Addiction Science & Clinical Practice, 17. doi: 10.1186/s13722-022-00349-8

Youth voices on treatment in the shadow of the overdose crisis. Key recommendations and findings for care providers.

(2022) Vancouver: British Columbia Centre on Substance Use

Rewarding recovery: the time is now for contingency management for opioid use disorder.

Proctor, Steven L (2022) Annals of Medicine, 54, (1), pp. 1178-1187. doi: 10.1080/07853890.2022.2068805

Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US.

Wang, Lindsey et al (2022) Molecular Psychiatry, Early online. doi.org/10.1038/s41380-022-01903-1

A systematic review on cannabis hyperemesis syndrome and its management options.

Senderovich, Helen et al (2022) Medical Principles and Practice, 31. pp. 29-38. doi: 10.1159/000520417

Association of recreational cannabis legalization with cannabis possession arrest rates in the US.

Gunadi, Christian and Shi, Yuyan (2022) JAMA Network Open, 5, (12). doi: 10.1001/jamanetworkopen.2022.44922

Known unknowns of medical cannabis.

Kowalski, Katya (2022) London: Volteface.

‘What discretion do you need?’ Factors influencing police decision-making in possession of cannabis offences.

Grace, Sharon et al (2022) Criminology & Criminal Justice, doi.org/10.1177/17488958221142478

Association of a positive drug screening for cannabis with mortality and hospital visits among veterans affairs enrollees prescribed opioids.

Keyhani, Salomeh et al (2022) JAMA Network Open, 5, (12). doi: 10.1001/jamanetworkopen.2022.47201

Alcohol: no ordinary commodity: research and public policy.

Babor, Thomas F et al (2022) Oxford University Press.

Alcohol: no ordinary commodity-a summary of the third edition.

Babor, Thomas F et al (2022) Addiction, 117, (12), pp. 3024-3036. doi.org/10.1111/add.16003

‘You’re in the alcohol Matrix, then you unplug from it, and you’re like ‘Wow’’’: exploring sober women’s management, negotiation and countering of alcohol marketing in the UK

Atkinson, A M et al (2022) Drugs: Education Prevention and Policy, doi.org/10.1080/09687637.2022.2145935

Webinar: Women, men and alcohol: why is gender important in alcohol control policies.

(2022) World Health Organization

Webinar: Reducing exposure to alcogenic environments among young people: what can be learned from community-led approaches?

World Health Organization (2022)

Alcohol use during pregnancy and motherhood: attitudes and experiences of pregnant women, mothers, and healthcare professionals.

Ujhelyi Gomez, Katalin et al (2022) PLoS ONE, 17, (12). doi: 10.1371/journal.pone.0275609

Uncorking big alcohol in the EU. A mapping of the European alcohol industry and its lobbying efforts against public health in the EU institutions.

(2022) Stockholm: IOGT-NTO and Movendi International.

Social work and fetal alcohol spectrum disorders (FASD).

Hall, Trisha et al (2022) Iriss Insights, 68.

Age-based differences in quantity and frequency of consumption when screening for harmful alcohol use.

Callinan, Sarah et al (2022) Addiction, 117, (9), pp. 2431-2437. doi: 10.1111/add.15904

Characterization of problematic alcohol use among physicians: a systematic review

Wilson, Janet et al (2022) JAMA Network Open, 5, (12). doi: 10.1001/jamanetworkopen.2022.44679

Estimating child maltreatment cases that could be alcohol-attributable in New Zealand

Huckle, Taisia and Romeo, Jose S (2022) Addiction, Early online. doi: 10.1111/add.16111 (In Press)

Effectiveness of a French mass media campaign in raising knowledge of both long-term alcohol-related harms and low-risk drinking guidelines, and in lowering alcohol consumption

Quatremère, Guillemette et al (2022) Addiction, Early online. doi.org/10.1111/add.16107

Alcohol-specific deaths in the UK: registered in 2021.

(2022) London: Office for National Statistics

Alcohol consumption and MRI markers of brain structure and function: cohort study of 25,378 UK Biobank participants.

Topiwala, Anya et al (2022) NeuroImage. Clinical, 35. doi.org/10.1016/j.nicl.2022.103066

Alcohol use contexts (social settings, drinking games/specials, and locations) as predictors of high-intensity drinking on a given day among U.S. young adults.

Terry-McElrath, Yvonne M et al (2022) Alcoholism, Clinical and Experimental Research, Early online. doi: 10.1111/acer.14985

Aging successfully, but still vulnerable: late life experiences of older adults who have recovered from alcohol use disorder.

Kermel-Schiffman, Ile and Gavriel-Fried, Belle (2022) International Journal of Geriatric Psychiatry, 37, (9). doi.org/10.1002/gps.5807

Association between alcohol use disorder and receipt of direct-acting antiviral Hepatitis C virus treatment

Haque, Lamia Y et al (2022) JAMA Network Open, 5, (12). 10.1001/jamanetworkopen.2022.46604

A critical review of recent knowledge of alcohol's effects on the immunological response in different tissues

Crotty, Kathryn et al (2022) Alcoholism, Clinical and Experimental Research, doi: 10.1111/acer.14979

E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials.

Hanewinkel, Reiner et al (2022) European Respiratory Review, 31, (163). doi: 10.1183/16000617.0215-2021

How and why do financial incentives contribute to helping people stop smoking?

A realist review protocol. Siersbaek, Rikke et al (2022) BMJ Open, 12, (6). doi.org/10.1136/bmjopen-2021-060457

An exploration of flavours in studies of e-cigarettes for smoking cessation: secondary analyses of a systematic review with meta-analyses.

Lindson, Nicola et al (2022) Addiction, Early online. doi: 10.1111/add.16091 (In Press)

Copyright © 2022 HRB National Drugs Library. All rights reserved.

The HRB National Drugs Library newsletter is a free subscriber-only monthly email newsletter offering relevant Irish and international news and information on alcohol and other drugs research. E-mail addresses provided for the purpose of subscribing to the newsletter will only be used by the library to distribute the requested information. The newsletter is published by the HRB National Drugs Library, Health Research Board. The library is staffed by qualified information professionals who handle a wide range of enquiries. Not sure what we can do for you? Email us and we will be happy to discuss your information needs.